The Original Investigation entitled “Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial,”1 published in the November 27, 2018, issue of JAMA, had a data error. In the Antidrug Antibodies subsection of the Results, the upper limit of the range of treatment-emergent antidrug antibodies should have been 1280. This article has been corrected online.
Reference
- 1.Banerji A, Riedl MA, Bernstein JA, et al. ; HELP Investigators . Effect of lanadelumab compared with placebo on prevention of hereditary angioedema attacks: a randomized clinical trial. JAMA. 2018;320(20):2108-2121. doi: 10.1001/jama.2018.16773 [DOI] [PMC free article] [PubMed] [Google Scholar]